3-{5,11-dioxo-5H,6H,11H-indeno[1,2-c]isoquinolin-6-yl}propyl 4-methylbenzene-1-sulfonate | 1259520-40-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 3-{5,11-dioxo-5H,6H,11H-indeno[1,2-c]isoquinolin-6-yl}propyl 4-methylbenzene-1-sulfonate
• 英文别名: 3-(5,11-dioxo-5H-indeno[1,2-c]isoquinolin-6(11H)-yl)propyl-4-methylbenzenesulfonate；3-(5,11-diketo-6H-indeno[1,2-c]isoquinolin-6-yl)propyl 4-methylbenzenesulfonate；3-(5,11-Dioxoindeno[1,2-c]isoquinolin-6-yl)propyl 4-methylbenzenesulfonate
• CAS: 1259520-40-5
• 化学式: C₂₆H₂₁NO₅S
• 分子量: 459.522
• InChiKey: DJTMGYVRDTZHTK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  33
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  89.1
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-叔丁氧羰基-1,2-乙二胺 、 3-{5,11-dioxo-5H,6H,11H-indeno[1,2-c]isoquinolin-6-yl}propyl 4-methylbenzene-1-sulfonate 以 乙腈 为溶剂， 反应 18.0h， 以80%的产率得到6-(3-(2-(Boc-amino)ethylamino)propyl)-6H-indeno[1,2-c]isoquinoline-5,11-dione
  参考文献：
  名称：

  Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties

  摘要：

  Three series of indeno[1,2-c]isoquinolin-5,11-dione-amino acid conjugates were designed and synthesized. Amino acids were connected to the tetracycle through linkers with lengths of n = 2 and 3 atoms using ester (series I), amide (series II), and secondary amine (series III) functions. DNA binding was evaluated by thermal denaturation and fluorescence measurements. Lysine and arginine substituted derivatives with n = 3 provided the highest DNA binding. Arginine derivative 32 (n = 2, series II) and glycine derivative 34 (n = 2, series III) displayed high topoisomerase II inhibition. Incrementing the length of the N-6 side chain from two to three methylene units provided a significant increase in DNA affinity but a substantial loss in topoisomerase II inhibition. The most cytotoxic compounds toward HL60 leukemia cells were 19, 33, and 34 displaying micromolar IC50 values. When tested with the topoisomerase II-mutated HL60/MX2 cell line, little variation of IC50 values was found, suggesting that topoisomerase II might not be the main target of these compounds and that additional targets could be involved. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.08.025
• 作为产物：
  描述：

  2-(2-Carboxyphenyl)-1,3-indandion 在 4-二甲氨基吡啶 、 水 、 对甲苯磺酸 、 三乙胺 作用下， 以 二氯甲烷 、 氯仿 、 苯 为溶剂， 反应 23.0h， 生成 3-{5,11-dioxo-5H,6H,11H-indeno[1,2-c]isoquinolin-6-yl}propyl 4-methylbenzene-1-sulfonate
  参考文献：
  名称：

  首个双酪氨酰-DNA 磷酸二酯酶 I (Tdp1)-拓扑异构酶 I (Top1) 抑制剂的合成和生物学评价

  摘要：

  在一种低分子量化合物中具有双重酪氨酰-DNA 磷酸二酯酶 I-拓扑异构酶 I 抑制活性的物质将构成一类独特的抗癌剂，可能比针对单个酶的药物具有显着的优势。本研究证明了基于茚并异喹啉化学型的第一个双 Top1-Tdp1 抑制剂的成功合成和评估。一种双（茚并异喹啉）对人 Tdp1 具有显着活性（IC 50= 1.52 ± 0.05 μM)，并且作为 Top1 抑制剂与喜树碱等效。通过该系列的结构-活性关系研究，获得了对酶-药物相互作用的重要见解。目前的结果还证明了先前报道的磺酰酯药效团未能在这种茚并异喹啉类抑制剂中赋予 Tdp1 抑制作用，尽管它被证明对类固醇 NSC 88915 有效 ( 7 )。目前的研究将促进未来优化双 Top1-Tdp1 抑制剂的努力。

  DOI：

  10.1021/jm300335n

文献信息

• SYNTHESIS AND USE OF DUAL TYROSYL-DNA PHOSPHODIESTERASE I (TDP1)- TOPOISOMERASE I (TOP1) INHIBITORS
  申请人：PURDUE RESEARCH FOUNDATION

  公开号：US20130345252A1

  公开（公告）日：2013-12-26

  The invention described herein pertains to the synthesis and use of certain N-substituted indenoisoquinoline compounds which inhibit the activity Tyrosyl-DNA Phosphodiesterase I (Tdp1) or Topoisomerase I (Top1) or both, or otherwise demonstrate anticancer activity. Also disclosed are novel N-substituted indenoisoquinoline compounds and pharmaceutical compositions comprising the novel N-substituted indenoisoquinoline compounds.

  本发明涉及合成和使用某些N-取代吲哚异喹啉化合物，这些化合物抑制酪氨酸-DNA磷酸二酯酶I（Tdp1）或拓扑异构酶I（Top1）或两者的活性，或表现出抗癌活性。还公开了新颖的N-取代吲哚异喹啉化合物和包含这些新颖的N-取代吲哚异喹啉化合物的药物组合物。
• Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties
  作者：Gang Ahn、Amélie Lansiaux、Jean-François Goossens、Christian Bailly、Brigitte Baldeyrou、Nadège Schifano-Faux、Pierre Grandclaudon、Axel Couture、Adina Ryckebusch

  DOI：10.1016/j.bmc.2010.08.025

  日期：2010.11.15

  Three series of indeno[1,2-c]isoquinolin-5,11-dione-amino acid conjugates were designed and synthesized. Amino acids were connected to the tetracycle through linkers with lengths of n = 2 and 3 atoms using ester (series I), amide (series II), and secondary amine (series III) functions. DNA binding was evaluated by thermal denaturation and fluorescence measurements. Lysine and arginine substituted derivatives with n = 3 provided the highest DNA binding. Arginine derivative 32 (n = 2, series II) and glycine derivative 34 (n = 2, series III) displayed high topoisomerase II inhibition. Incrementing the length of the N-6 side chain from two to three methylene units provided a significant increase in DNA affinity but a substantial loss in topoisomerase II inhibition. The most cytotoxic compounds toward HL60 leukemia cells were 19, 33, and 34 displaying micromolar IC50 values. When tested with the topoisomerase II-mutated HL60/MX2 cell line, little variation of IC50 values was found, suggesting that topoisomerase II might not be the main target of these compounds and that additional targets could be involved. (C) 2010 Elsevier Ltd. All rights reserved.
• Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)–Topoisomerase I (Top1) Inhibitors
  作者：Trung Xuan Nguyen、Andrew Morrell、Martin Conda-Sheridan、Christophe Marchand、Keli Agama、Alun Bermingam、Andrew G. Stephen、Adel Chergui、Alena Naumova、Robert Fisher、Barry R. O’Keefe、Yves Pommier、Mark Cushman

  DOI：10.1021/jm300335n

  日期：2012.5.10

  Substances with dual tyrosyl-DNA phosphodiesterase I–topoisomerase I inhibitory activity in one low molecular weight compound would constitute a unique class of anticancer agents that could potentially have significant advantages over drugs that work against the individual enzymes. The present study demonstrates the successful synthesis and evaluation of the first dual Top1–Tdp1 inhibitors, which are based

  在一种低分子量化合物中具有双重酪氨酰-DNA 磷酸二酯酶 I-拓扑异构酶 I 抑制活性的物质将构成一类独特的抗癌剂，可能比针对单个酶的药物具有显着的优势。本研究证明了基于茚并异喹啉化学型的第一个双 Top1-Tdp1 抑制剂的成功合成和评估。一种双（茚并异喹啉）对人 Tdp1 具有显着活性（IC 50= 1.52 ± 0.05 μM)，并且作为 Top1 抑制剂与喜树碱等效。通过该系列的结构-活性关系研究，获得了对酶-药物相互作用的重要见解。目前的结果还证明了先前报道的磺酰酯药效团未能在这种茚并异喹啉类抑制剂中赋予 Tdp1 抑制作用，尽管它被证明对类固醇 NSC 88915 有效 ( 7 )。目前的研究将促进未来优化双 Top1-Tdp1 抑制剂的努力。